<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="ml4" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">ml4</book-part-id>
      <title-group>
        <title>Mucolipidosis IV</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Schiffmann</surname>
            <given-names>Raphael</given-names>
          </name>
          <degrees>MD, MHSc</degrees>
          <aff>Director, Institute of Metabolic Disease<break/>Baylor Research Institute<break/>Dallas, Texas</aff>
          <email>raphael.schiffmann@baylorhealth.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Grishchuk</surname>
            <given-names>Yulia</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>MGH Center for Human Genetic Research / Harvard Medical School<break/>Boston, Massachusetts</aff>
          <email>ygrishchuk@mgh.harvard.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Goldin</surname>
            <given-names>Ehud</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Section on Molecular Neurogenetics <break/>Medical Genetics Branch <break/>National Human Genome Research Institute <break/>National Institutes of Health<break/>Bethesda, Maryland</aff>
          <email>goldine@mail.nih.gov</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>28</day>
          <month>1</month>
          <year>2005</year>
        </date>
        <date date-type="updated">
          <day>30</day>
          <month>7</month>
          <year>2015</year>
        </date>
        <date date-type="revised">
          <day>1</day>
          <month>12</month>
          <year>2005</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="ml3c" document-type="chapter">Mucolipidosis III Gamma</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="mps1" document-type="chapter">Mucopolysaccharidosis Type I</related-object>
      <abstract id="ml4.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Mucolipidosis IV is characterized by severe psychomotor delay evident by the end of the first year of life and slowly progressive visual impairment during the first decade as a result of a combination of corneal clouding and retinal degeneration. By the end of the first decade of life and certainly by their early teens, all individuals with typical mucolipidosis IV have severe visual impairment as a result of retinal degeneration. Neurodegeneration is thought to occur in no more than 15% of individuals. About 5% of individuals have atypical mucolipidosis IV, often manifest as less severe psychomotor retardation and/or eye findings. Although in the past, mucolipidosis IV was considered an Ashkenazi Jewish disease, currently most affected individuals are non-Ashkenazi Jewish.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Mucolipidosis IV is suspected in individuals with typical clinical findings and elevated plasma gastrin concentration or polymorphic lysosomal inclusions in skin or conjunctival biopsy. Identification of biallelic pathogenic variants in <italic toggle="yes">MCOLN1</italic> confirms the diagnosis. The two variants, c.406-2A&#x0003e;G and 6.4 kb del (also known as g.511_6943del), account for 95% of pathogenic variants in individuals of Ashkenazi Jewish heritage.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Speech therapy; physical therapy for spasticity and ataxia; ankle-foot orthotics (AFOs) as needed; antiepileptic drugs as needed; topical lubricating eye drops, artificial tears, gels, or ointments for ocular irritation; surgical correction of strabismus; high-contrast black and white materials for those with visual impairment.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Physical therapy to prevent permanent joint contractures; oral iron to prevent iron deficiency anemia from poor absorption of dietary iron.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Mucolipidosis IV is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible for families in which both <italic toggle="yes">MCOLN1</italic> pathogenic variants have been identified.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="ml4.Diagnosis">
        <title>Diagnosis</title>
        <sec id="ml4.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Mucolipidosis IV <bold>should be suspected</bold> in any individual with the following clinical and laboratory findings.</p>
          <p>
            <bold>Clinical findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Early onset of developmental delay whether static, as in cerebral palsy, or progressively declining with loss of previously acquired cognitive and motor abilities [<xref ref-type="bibr" rid="ml4.REF.altarescu.2002.306">Altarescu et al 2002</xref>]</p>
            </list-item>
            <list-item>
              <p>Dystrophic retinopathy with or without corneal clouding [<xref ref-type="bibr" rid="ml4.REF.smith.2002.588">Smith et al 2002</xref>]</p>
            </list-item>
          </list>
          <p><bold>Laboratory findings.</bold> Plasma gastrin concentration is elevated in virtually all individuals with mucolipidosis IV (mean 1507 pg/mL; range 400-4100 pg/mL) (normal 0-200 pg/mL) [<xref ref-type="bibr" rid="ml4.REF.schiffmann.1998.1207">Schiffmann et al 1998</xref>, <xref ref-type="bibr" rid="ml4.REF.altarescu.2002.306">Altarescu et al 2002</xref>].</p>
        </sec>
        <sec id="ml4.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of mucolipidosis IV <bold>is established</bold> in a proband with biallelic pathogenic variants in <italic toggle="yes">MCOLN1</italic> (see <xref ref-type="table" rid="ml4.T.summary_of_molecular_genetic_testi">Table 1</xref>) or (if molecular genetic testing is unavailable and/or uninformative) identification of characteristic inclusions on <xref ref-type="sec" rid="ml4.Biopsy">skin biopsy or conjunctival swab</xref>.</p>
          <sec id="ml4.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p>Approaches can include <bold>single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive</bold>
<bold>genomic testing</bold>.</p>
            <p><bold>Single-gene testing.</bold> Sequence analysis of <italic toggle="yes">MCOLN1</italic> is performed first, followed by gene-targeted deletion/duplication analysis if only one or no pathogenic variant is found.</p>
            <p>In individuals of Ashkenazi Jewish ancestry targeted analysis for the two common pathogenic variants &#x02013; <xref ref-type="table" rid="ml4.T.selected_mcoln1_pathogenic_variant">c.406-2A&#x0003e;G</xref> and a 6.4-kb deletion beginning in the 5&#x02019;UTR and extending into exon 6 &#x02013; can be performed first, as they account for 95% of pathogenic variants in this population. An estimated 70% of individuals with mucolipidosis IV are of Ashkenazi Jewish heritage [<xref ref-type="bibr" rid="ml4.REF.altarescu.2002.306">Altarescu et al 2002</xref>].</p>
            <list list-type="bullet">
              <list-item>
                <p>Approximately 60% of individuals with mucolipidosis IV of Ashkenazi Jewish heritage in the US are homozygotes for the c.406-2A&#x0003e;G intronic acceptor splice site pathogenic variant.</p>
              </list-item>
              <list-item>
                <p>An estimated 33% are compound heterozygotes for the two common pathogenic variants [<xref ref-type="bibr" rid="ml4.REF.wang.2001.87">Wang et al 2001</xref>, <xref ref-type="bibr" rid="ml4.REF.goldin.2004a.460">Goldin et al 2004a</xref>].</p>
              </list-item>
              <list-item>
                <p>Only one individual homozygous for the 6.4-kb deletion has been identified [<xref ref-type="bibr" rid="ml4.REF.bargal.2000.118">Bargal et al 2000</xref>, <xref ref-type="bibr" rid="ml4.REF.bassi.2000.1110">Bassi et al 2000</xref>, <xref ref-type="bibr" rid="ml4.REF.sun.2000.2471">Sun et al 2000</xref>].</p>
              </list-item>
            </list>
            <p>Note: The common 6.4-kb deletion cannot be detected by routine sequencing. Other methods such as gene-targeted deletion/duplication analysis or a genotyping assay specifically designed to detect this deletion (e.g., breakpoint PCR or allele-specific primer extension) must be employed.</p>
            <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">MCOLN1</italic> and other genes of interest (see <xref ref-type="sec" rid="ml4.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: The genes included and sensitivity of multi-gene panels vary by laboratory and over time.</p>
            <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing, genome sequencing, and mitochondrial sequencing may be considered if serial single-gene testing (and/or use of a multi-gene panel) fails to confirm a diagnosis in an individual with features of mucolipidosis IV. For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            <table-wrap id="ml4.T.summary_of_molecular_genetic_testi" orientation="portrait" position="anchor">
              <label>Table 1. </label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in Mucolipidosis IV</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_2">Test Method</th>
                    <th id="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th>
                  </tr>
                  <tr>
                    <th headers="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_3" id="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Ashkenazi Jewish</th>
                    <th headers="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_3" id="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Non-Ashkenazi Jewish</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">MCOLN1</italic>
                    </td>
                    <td headers="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Targeted analysis for pathogenic variants&#x000a0;<sup>3</sup></td>
                    <td headers="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_3 hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">95%</td>
                    <td headers="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_3 hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">6%-10%</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Sequence analysis&#x000a0;<sup>4,&#x000a0;5</sup></td>
                    <td headers="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_3 hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">77%-81%</td>
                    <td headers="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_3 hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">99%</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>6,&#x000a0;7</sup></td>
                    <td headers="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_3 hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">18% / unknown&#x000a0;<sup>8</sup></td>
                    <td headers="hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_1_3 hd_h_ml4.T.summary_of_molecular_genetic_testi_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>8</sup></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="ml4.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="ml4" object-id="ml4.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="ml4.TF.1.2">
                  <label>2. </label>
                  <p>See <xref ref-type="sec" rid="ml4.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
                </fn>
                <fn id="ml4.TF.1.3">
                  <label>3. </label>
                  <p>For the pathogenic variants <xref ref-type="table" rid="ml4.T.selected_mcoln1_pathogenic_variant">c.406-2A&#x0003e;G</xref> (77%) and 6.4 kb del (18%). Note: Reported breakpoints for this deletion vary slightly; see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=MCOLN1">HGMD</ext-link>.</p>
                </fn>
                <fn id="ml4.TF.1.4">
                  <label>4. </label>
                  <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="ml4.TF.1.5">
                  <label>5. </label>
                  <p>Cannot detect <xref ref-type="table" rid="ml4.T.selected_mcoln1_pathogenic_variant">6.4 kb del</xref>, one the two pathogenic variants common in persons of Ashkenazi Jewish heritage</p>
                </fn>
                <fn id="ml4.TF.1.6">
                  <label>6. </label>
                  <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used can include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
                </fn>
                <fn id="ml4.TF.1.7">
                  <label>7. </label>
                  <p>Required to detect the common 6.4-kb deletion observed in persons of Ashkenazi Jewish heritage and other novel (multi)exon deletions. Note that other genotyping assays specifically designed to detect the 6.4-kb deletion (e.g., breakpoint PCR or allele-specific primer extension) may be employed.</p>
                </fn>
                <fn id="ml4.TF.1.8">
                  <label>8. </label>
                  <p>No data on detection rate of non-6.4-kb deletion gene-targeted deletion/duplication analysis are available.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
          <sec id="ml4.Biopsy">
            <title>Biopsy</title>
            <p>In the past, identification of abnormal lamellar membrane structures and amorphous cytoplasmic inclusions in diverse cell types on skin biopsy was used to confirm the diagnosis of mucolipidosis IV [<xref ref-type="bibr" rid="ml4.REF.bargal.2002.199">Bargal et al 2002</xref>]. Subsequently, demonstration of typical vacuolation by PAS staining of conjunctival cells obtained with a swab was used for diagnosis [<xref ref-type="bibr" rid="ml4.REF.smith.2002.588">Smith et al 2002</xref>].</p>
          </sec>
        </sec>
      </sec>
      <sec id="ml4.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="ml4.Clinical_Description">
          <title>Clinical Description</title>
          <p>Mucolipidosis IV is a neurodevelopmental disorder that is also neurodegenerative in about 15% of individuals. The phenotype in affected individuals can be either typical (~95% of individuals) or atypical (~5% of individuals) [<xref ref-type="bibr" rid="ml4.REF.altarescu.2002.306">Altarescu et al 2002</xref>]. Although individuals with mucolipidosis IV generally survive to adulthood, life expectancy is reduced compared to healthy individuals.</p>
          <sec id="ml4.Typical_Mucolipidosis_IV">
            <title>Typical Mucolipidosis IV</title>
            <p>The most common presentation is severe psychomotor delay by the end of the first year of life in a child who is subsequently noted to have visual impairment caused by a combination of corneal clouding and retinal degeneration.</p>
            <p><bold>Neurologic findings.</bold> Psychomotor development is usually limited to few or no words and poor hand use [<xref ref-type="bibr" rid="ml4.REF.altarescu.2002.306">Altarescu et al 2002</xref>]; some may develop the ability to sit independently or crawl. Most individuals do not achieve independent walking [<xref ref-type="bibr" rid="ml4.REF.altarescu.2002.306">Altarescu et al 2002</xref>]; a few have learned to walk with the aid of a walker [<xref ref-type="bibr" rid="ml4.REF.altarescu.2002.306">Altarescu et al 2002</xref>].</p>
            <p>Receptive language is better than expressive language; some individuals have used up to 50 signs to communicate.</p>
            <p>Neurologic examination typically reveals severe dysarthria or anarthria, slow chewing, slow eating and swallowing, and spastic diplegia or quadriplegia [<xref ref-type="bibr" rid="ml4.REF.altarescu.2002.306">Altarescu et al 2002</xref>]. Individuals may be hypotonic, but tendon reflexes are usually hyperactive.</p>
            <p>Neurologic deficits generally remain static during the first three decades of life [<xref ref-type="bibr" rid="ml4.REF.altarescu.2002.306">Altarescu et al 2002</xref>]; however, some individuals have neurologic deterioration best observed by serial brain magnetic resonance imaging volumetry and diffusion weighted imaging [<xref ref-type="bibr" rid="ml4.REF.schiffmann.2014.147">Schiffmann et al 2014</xref>].</p>
            <p>Brain MRI typically shows hypoplasia of the corpus callosum with absent rostrum and a dysplastic or absent splenium, signal abnormalities in the white matter on T<sub>1</sub>-weighted images, and increased ferritin deposition in the thalamus and basal ganglia. Atrophy of the cerebellum is observed in older individuals [<xref ref-type="bibr" rid="ml4.REF.frei.1998.565">Frei et al 1998</xref>].</p>
            <p>Epileptiform discharges on EEG are common but are infrequently associated with clinical seizures [<xref ref-type="bibr" rid="ml4.REF.siegel.1998.400">Siegel et al 1998</xref>].</p>
            <p><bold>Eye findings.</bold> Individuals with typical mucolipidosis IV have superficial corneal clouding that is bilateral, symmetric, and most visible in the central cornea [<xref ref-type="bibr" rid="ml4.REF.smith.2002.588">Smith et al 2002</xref>]. The corneal opacification is limited to the epithelium without stromal involvement or edema [Authors, personal observation], early reports of stromal abnormalities notwithstanding. On occasion, corneal clouding is the feature that prompts medical evaluation.</p>
            <p>Painful episodes consistent with corneal erosions are common, but appear to decrease in frequency and severity with age.</p>
            <p>Vision may be close to normal at a young age. Over the first decade of life, progressive retinal degeneration with varying degrees of vascular attenuation, retinal pigment epithelial changes, and optic nerve pallor result in further decrease in vision [<xref ref-type="bibr" rid="ml4.REF.siegel.1998.400">Siegel et al 1998</xref>, <xref ref-type="bibr" rid="ml4.REF.altarescu.2002.306">Altarescu et al 2002</xref>, <xref ref-type="bibr" rid="ml4.REF.pradhan.2002.45">Pradhan et al 2002</xref>, <xref ref-type="bibr" rid="ml4.REF.smith.2002.588">Smith et al 2002</xref>]. Bilateral bull's eye maculopathy was observed in one individual [<xref ref-type="bibr" rid="ml4.REF.smith.2002.588">Smith et al 2002</xref>]. Visual acuity is difficult to test in most individuals with mucolipidosis IV, but is decreased in almost all persons older than age five years. Virtually all individuals with mucolipidosis IV develop severe visual impairment by their early teens as a result of the retinal degeneration.</p>
            <p>In rare instances, mucolipidosis IV may consist of isolated retinal dystrophy [<xref ref-type="bibr" rid="ml4.REF.goldin.2008.3134">Goldin et al 2008</xref>].</p>
            <p>Other ocular findings are strabismus (&#x0003e;50% of individuals), nystagmus, ptosis, and cataract [<xref ref-type="bibr" rid="ml4.REF.bach.2001.197">Bach 2001</xref>, <xref ref-type="bibr" rid="ml4.REF.smith.2002.588">Smith et al 2002</xref>]. The pupillary response to light is usually sluggish without evidence of relative afferent pupillary defect [<xref ref-type="bibr" rid="ml4.REF.smith.2002.588">Smith et al 2002</xref>].</p>
            <p><bold>Renal findings.</bold> Progressive renal failure which has been recognized in recent years is now considered a feature of the classic form of mucolipidosis IV. It manifests itself in the third decade of life [Author, unpublished data]. Because of chronic muscle atrophy in mucolipidosis IV, blood cystatin c level is the most sensitive way to diagnose renal insufficiency.</p>
            <p><bold>Other.</bold> Iron deficiency occurs in about 50% of affected individuals, and iron deficiency anemia, which is usually well tolerated, occurs in about 10% of affected individuals [<xref ref-type="bibr" rid="ml4.REF.altarescu.2002.306">Altarescu et al 2002</xref>].</p>
            <p>The achlorhydria is asymptomatic.</p>
            <p>The face is not typically coarse but has typical features [<xref ref-type="bibr" rid="ml4.REF.goldin.b">Goldin et al 2004b</xref>].</p>
            <p>Affected individuals do not have hepatosplenomegaly or specific skeletal abnormalities.</p>
          </sec>
          <sec id="ml4.Atypical_and_Mild_Mucolipidosis_IV">
            <title>Atypical and Mild Mucolipidosis IV</title>
            <p>Individuals with atypical mucolipidosis IV are less severely affected than individuals with typical mucolipidosis IV or have one organ system disproportionately affected [<xref ref-type="bibr" rid="ml4.REF.altarescu.2002.306">Altarescu et al 2002</xref>].</p>
            <p>Some individuals attain the ability to walk independently or have isolated dystrophic retinopathy without neurologic dysfunction [<xref ref-type="bibr" rid="ml4.REF.goldin.2008.3134">Goldin et al 2008</xref>]. They develop slowly progressive ataxia, have mild eye abnormalities, and are usually of non-Ashkenazi Jewish descent [<xref ref-type="bibr" rid="ml4.REF.altarescu.2002.306">Altarescu et al 2002</xref>].</p>
            <p>Some present with a congenital myopathy with significant generalized hypotonia and elevated serum muscle creatine kinase (CK) concentration.</p>
            <p>Some present with static (non-progressive) motor and cognitive delay and minimal ocular abnormalities.</p>
            <list list-type="bullet">
              <list-item>
                <p>One female who presented with progressive visual impairment with corneal clouding with the appearance of cornea verticillata, retinopathy, normal psychomotor development, and behavioral abnormalities developed unstable gait in her twenties [<xref ref-type="bibr" rid="ml4.REF.altarescu.2002.306">Altarescu et al 2002</xref>].</p>
              </list-item>
              <list-item>
                <p>Two other individuals with no neurologic deficit were diagnosed based on ocular findings [<xref ref-type="bibr" rid="ml4.REF.dobrovolny.2007.663">Dobrovolny et al 2007</xref>, <xref ref-type="bibr" rid="ml4.REF.goldin.2008.3134">Goldin et al 2008</xref>]. These individuals had all the other typical features of mucolipidosis IV including achlorhydria and autofluorescent inclusions in cultured skin fibroblasts [<xref ref-type="bibr" rid="ml4.REF.dobrovolny.2007.663">Dobrovolny et al 2007</xref>, <xref ref-type="bibr" rid="ml4.REF.goldin.2008.3134">Goldin et al 2008</xref>].</p>
              </list-item>
            </list>
          </sec>
        </sec>
        <sec id="ml4.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Individuals of Ashkenazi Jewish ancestry usually have the severe form of mucolipidosis IV.</p>
          <p>A pathogenic variant that creates a new preferred splice site of <italic toggle="yes">MCOLN1,</italic>
<xref ref-type="table" rid="ml4.T.selected_mcoln1_pathogenic_variant">c.1406A&#x0003e;G</xref> (p.Phe454_Asn569del) was identified in a Canadian family from Newfoundland; it causes an atypical form of mucolipidosis IV, in which affected individuals walk independently and have better communicative skills [<xref ref-type="bibr" rid="ml4.REF.altarescu.2002.306">Altarescu et al 2002</xref>].</p>
          <p><bold>Variants in the loop between the first and second transmembrane domain.</bold> Pathogenic variants found in the loop between the first and second transmembrane domain, one in the lipase domain and one eliminating one of the four cysteines in the loop, possibly reduce the stability of mucolipin-1. Individuals with these pathogenic variants had a mild phenotype, an independent ataxic gait, and the ability to use their hands to feed themselves.</p>
          <p>The typical, rather severe presentation associated with the <xref ref-type="table" rid="ml4.T.selected_mcoln1_pathogenic_variant">c.694A&#x0003e;C</xref> (p.Thr232Pro) pathogenic variant in the same region may be explained by the fact that the abnormal protein does not reach the endocytic compartment and accumulates in the endoplasmic reticulum [<xref ref-type="bibr" rid="ml4.REF.manzoni.2004.219">Manzoni et al 2004</xref>].</p>
          <p><bold>Variants in the third transmembrane domain.</bold> In several individuals from the southeast United States, a c.1084G&#x0003e;T (<xref ref-type="table" rid="ml4.T.selected_mcoln1_pathogenic_variant">p.Asp362Tyr</xref>) pathogenic variant was identified in the third transmembrane domain. This pathogenic variant was associated with a slower progression of the retinal disease and a relatively mild neurologic phenotype, although membrane preparations containing mucolipin-1 with this pathogenic variant had no channel activity [<xref ref-type="bibr" rid="ml4.REF.raychowdhury.2004.617">Raychowdhury et al 2004</xref>].</p>
          <p><bold>Variants in the fourth transmembrane domain.</bold> Several <italic toggle="yes">MCOLN1</italic> pathogenic variants are in the fourth transmembrane domain, including c.1221_1223delCTT (<xref ref-type="table" rid="ml4.T.selected_mcoln1_pathogenic_variant">p.Phe408del</xref>), which causes the mildest mucolipidosis IV phenotype known [<xref ref-type="bibr" rid="ml4.REF.altarescu.2002.306">Altarescu et al 2002</xref>].</p>
          <p><bold>Variants between the fifth and sixth transmembrane domain.</bold> Several other pathogenic variants are in the area encoding the presumed channel pore between the fifth and sixth transmembrane domain. Most of those were associated with a severe mucolipidosis IV phenotype (<xref ref-type="table" rid="ml4.T.selected_mcoln1_pathogenic_variant">Table 3</xref>) [<xref ref-type="bibr" rid="ml4.REF.altarescu.2002.306">Altarescu et al 2002</xref>].</p>
        </sec>
        <sec id="ml4.Nomenclature">
          <title>Nomenclature</title>
          <p>Mucolipidosis IV was classified as a mucolipidosis because of the initial impression of simultaneous storage of lipids and water-soluble substances.</p>
        </sec>
        <sec id="ml4.Prevalence">
          <title>Prevalence</title>
          <p>The combined carrier frequency of the two pathogenic variants common in persons of Ashkenazi Jewish descent ranges from 1:100 to 1:127 [<xref ref-type="bibr" rid="ml4.REF.bargal.2001.397">Bargal et al 2001</xref>, <xref ref-type="bibr" rid="ml4.REF.edelmann.2002.1023">Edelmann et al 2002</xref>]. Of note, in a small group of 123 individuals, other investigators found a higher frequency [<xref ref-type="bibr" rid="ml4.REF.wang.2001.87">Wang et al 2001</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p>The splice pathogenic variant (c.406-2A&#x0003e;G) is at least three times more common than the deletion pathogenic variant (6.4-kb del) [<xref ref-type="bibr" rid="ml4.REF.edelmann.2002.1023">Edelmann et al 2002</xref>].</p>
            </list-item>
            <list-item>
              <p>The deletion variant is particularly rare in the Israeli population (1:2000) in comparison to its frequency in the New York metropolitan area (1:406) [<xref ref-type="bibr" rid="ml4.REF.bargal.2001.397">Bargal et al 2001</xref>, <xref ref-type="bibr" rid="ml4.REF.edelmann.2002.1023">Edelmann et al 2002</xref>].</p>
            </list-item>
          </list>
          <p>Prior to the availability of molecular diagnosis of mucolipidosis IV, individuals with atypical mucolipidosis IV were thought to have cerebral palsy, suggesting that mucolipidosis IV is underdiagnosed.</p>
        </sec>
      </sec>
      <sec id="ml4.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are associated with pathogenic variants in <italic toggle="yes">MCOLN1</italic>.</p>
      </sec>
      <sec id="ml4.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Because of the relatively static nature of the neurologic abnormality in mucolipidosis IV, individuals considered to have "cerebral palsy" should be evaluated for mucolipidosis IV.</p>
        <p>The neurologic abnormalities and the finding of widespread storage material in tissue biopsy could suggest other lysosomal storage disorders including mucolipidosis type I (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/256550">256550</ext-link>), <related-object link-type="booklink" source-id="gene" document-id="ml2" document-type="chapter">mucolipidosis type II</related-object>, and the mucopolysaccharidoses (<related-object link-type="booklink" source-id="gene" document-id="mps1" document-type="chapter">MPS I</related-object>, <related-object link-type="booklink" source-id="gene" document-id="hunter" document-type="chapter">MPS II</related-object>, <related-object link-type="booklink" source-id="gene" document-id="mps4a" document-type="chapter">MPS IVA</related-object>, <related-object link-type="booklink" source-id="gene" document-id="gm1-ganglio" document-type="chapter">MPS IVB</related-object>). See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/phenotypicSeries/PS607014">Mucopolysaccharidoses: OMIM Phenotypic Series</ext-link> to view genes associated with this phenotype in OMIM.</p>
        <p>The finding of white matter abnormalities and a thin dysplastic corpus callosum could suggest other inherited hypomyelinating leukodystrophies such as sialic acid storage disease (Salla disease). (See <related-object link-type="booklink" source-id="gene" document-id="issd" document-type="chapter">Free Sialic Acid Storage Disorders</related-object> and <related-object link-type="booklink" source-id="gene" document-id="leukodys-ov" document-type="chapter">Leukodystrophy Overview</related-object>.)</p>
        <p>Corneal clouding also occurs in:</p>
        <list list-type="bullet">
          <list-item>
            <p>The mucopolysaccharidoses: <related-object link-type="booklink" source-id="gene" document-id="mps1" document-type="chapter">MPS I</related-object>, MPS III (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/252900">252900</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/252930">252930</ext-link>), <related-object link-type="booklink" source-id="gene" document-id="mps4a" document-type="chapter">MPS IVA</related-object>, <related-object link-type="booklink" source-id="gene" document-id="gm1-ganglio" document-type="chapter">MPS IVB</related-object>, MPS VI (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/253200">253200</ext-link>);</p>
          </list-item>
          <list-item>
            <p>Mucolipidosis (<related-object link-type="booklink" source-id="gene" document-id="ml2" document-type="chapter">ML II</related-object>, <related-object link-type="booklink" source-id="gene" document-id="ml3a" document-type="chapter">ML III Alpha/Beta</related-object>, <related-object link-type="booklink" source-id="gene" document-id="ml3c" document-type="chapter">ML III Gamma</related-object>);</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="gm1-ganglio" document-type="chapter">GM1 gangliosidosis</related-object>.</p>
          </list-item>
        </list>
        <p>Cornea verticillata (without retinal dystrophy) occurs in <related-object link-type="booklink" source-id="gene" document-id="fabry" document-type="chapter">Fabry disease</related-object>.</p>
        <p>The retinal dystrophy of mucolipidosis IV is similar to that observed in the <related-object link-type="booklink" source-id="gene" document-id="ncl" document-type="chapter">neuronal ceroid-lipofuscinoses</related-object> and other genetic disorders with retinal degeneration such as <related-object link-type="booklink" source-id="gene" document-id="bbs" document-type="chapter">Bardet-Biedl syndrome</related-object> and <related-object link-type="booklink" source-id="gene" document-id="alstrom" document-type="chapter">Alstr&#x000f6;m syndrome</related-object>.</p>
      </sec>
      <sec id="ml4.Management">
        <title>Management</title>
        <sec id="ml4.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with mucolipidosis IV, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Ophthalmic examination</p>
            </list-item>
            <list-item>
              <p>Brain MRI</p>
            </list-item>
            <list-item>
              <p>Iron studies</p>
            </list-item>
            <list-item>
              <p>Neurologic evaluation, including EEG</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="ml4.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>The following treatment is appropriate:</p>
          <list list-type="bullet">
            <list-item>
              <p>Speech therapy</p>
            </list-item>
            <list-item>
              <p>Physical therapy and rehabilitation for motor dysfunction (mainly spasticity and ataxia)</p>
            </list-item>
            <list-item>
              <p>Ankle-foot orthotics in individuals with hypotonia and weakness of ankle dorsiflexion</p>
            </list-item>
            <list-item>
              <p>Antiepileptic drugs</p>
            </list-item>
            <list-item>
              <p>Topical lubricating eye drops, artificial tears, gels, or ointments for management of the intermittent ocular irritation seen frequently in younger children</p>
            </list-item>
            <list-item>
              <p>Surgical correction of strabismus</p>
            </list-item>
            <list-item>
              <p>High-contrast black and white materials for those with visual impairment</p>
            </list-item>
          </list>
          <p>Note: Corneal transplantation has not been successful because the donor corneal epithelium is eventually replaced by the abnormal host epithelium.</p>
        </sec>
        <sec id="ml4.Prevention_of_Secondary_Complication">
          <title>Prevention of Secondary Complications</title>
          <p>Physical therapy and rehabilitation can help prevent permanent joint contractures.</p>
          <p>An iron preparation such as oral ferrous sulfate is indicated for treatment of iron deficiency anemia resulting from poor absorption of dietary iron.</p>
        </sec>
        <sec id="ml4.Surveillance">
          <title>Surveillance</title>
          <p>Annual follow up with a generalist is appropriate.</p>
        </sec>
        <sec id="ml4.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Chloroquine may be contraindicated, based on published research in patient cultured skin fibroblasts [<xref ref-type="bibr" rid="ml4.REF.goldin.1999.8562">Goldin et al 1999</xref>].</p>
        </sec>
        <sec id="ml4.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="ml4.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="ml4.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="ml4.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="ml4.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Mucolipidosis IV is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="ml4.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">MCOLN1</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Individuals with mucolipidosis IV do not reproduce. No information is available regarding the ability of individuals with mild disease to reproduce.</p>
          <p><bold>Other family members of a proband.</bold> Each sib of the proband's parents is at a 50% risk of being a carrier of an <italic toggle="yes">MCOLN1</italic> pathogenic variant.</p>
        </sec>
        <sec id="ml4.Heterozygote_Carrier_Detection">
          <title>Heterozygote (Carrier) Detection</title>
          <p>Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">MCOLN1</italic> pathogenic variants in the family.</p>
        </sec>
        <sec id="ml4.Population_Screening">
          <title>Population Screening</title>
          <p>Because of the high carrier rate in individuals of Ashkenazi Jewish descent and the availability of premarital, preconception, and prenatal genetic counseling as well as prenatal diagnosis, the two <italic toggle="yes">MCOLN1</italic> pathogenic variants commonly seen in persons of Ashkenazi Jewish heritage are often included in the panel of "Ashkenazi Jewish mutations" offered to individuals interested in preconception or prenatal risk assessment modification. Through this type of screening, couples in which both partners are carriers can be made aware of their status and risks before having affected children. Through genetic counseling and the option of prenatal testing, such families can, if they choose, bring to term only those pregnancies in which the fetus is unaffected.</p>
        </sec>
        <sec id="ml4.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="ml4.Prenatal_Testing_and_Preimplantation">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">MCOLN1</italic> pathogenic variants have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for mucolipidosis IV are possible.</p>
        </sec>
      </sec>
      <sec id="ml4.Resources">
        <title>Resources</title>
      </sec>
      <sec id="ml4.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="ml4.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>The lysosomal storage of lipids and water-soluble substances in mucolipidosis IV is attributed to a transport defect in the late steps of endocytosis resulting from abnormal membrane components of endosomes. Endosomes shuttle lipids and proteins between the plasma membrane and the various cellular organelles. Nutrients bound to lysosomes for processing would be retained in these transition vesicles. Alternatively it could indicate an increased rate of membrane recycling resulting from rapid degradation of malfunctioning protein complexes at the plasma membrane. Inability of cells to compensate for the missing cation channel function causes the defect in organization of white matter in the brain and reduces maintenance of cells in the retina and optic nerve. Inability to secrete gastric acid may be directly related to a defect in the operation of the acid-secreting H<sup>+</sup>K<sup>+</sup> ATPase in stomach parietal cells.</p>
          <p>In <italic toggle="yes">C. elegans</italic> a pathogenic variant in an ABC transporter gene compensates for mucolipin deficiency and leads to viable worms, indicating that loss of a regulatory effect of mucolipin on the activity of the transporter is probably the cause of death in mucolipin-deficient worms [<xref ref-type="bibr" rid="ml4.REF.schaheen.2006.382">Schaheen et al 2006</xref>].</p>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">MCOLN1</italic> spans 12,300 base pairs and comprises 14 exons. In humans, no expressed splice variants are known.</p>
          <p><bold>Benign variants.</bold> A single-nucleotide polymorphism, c.984C&#x0003e;T (p.Asn328Asn), results in no amino acid change (reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_020533.1">NM_020533.1</ext-link>).</p>
          <p><bold>Pathogenic variants.</bold> A variety of pathogenic variants cause mucolipidosis IV, including pathogenic splice variants, small and large deletions and insertions, and pathogenic nonsense and missense variants (<xref ref-type="table" rid="ml4.T.selected_mcoln1_pathogenic_variant">Table 3</xref>).</p>
          <p>The two most prevalent pathogenic variants cause the majority of mucolipidosis IV in the Ashkenazi Jewish population.</p>
          <list list-type="bullet">
            <list-item>
              <p>One is the splice variant c.406-2A&#x0003e;G, which prevents splicing of mucolipin-1 mRNA at exon 4, resulting in a mix of unstable aberrant mRNA species.</p>
            </list-item>
            <list-item>
              <p>The second, 6.4 kb del (also known as g.511_6943del), is a deletion of 6434 bp of DNA, including exons 1 through 5 and part of exon 6 of <italic toggle="yes">MCOLN1</italic>. A Polish individual with a non-Jewish haplotype was found to be heterozygous for this pathogenic variant [<xref ref-type="bibr" rid="ml4.REF.sun.2000.2471">Sun et al 2000</xref>].</p>
            </list-item>
          </list>
          <p>Pathogenic missense variants were found in the loop between the first and second transmembrane domain, one in the lipase domain, and one eliminating the four cysteines in the loop, possibly reducing the stability of mucolipin. See <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="ml4-Table2.pdf" content-type="local-data">Table 2</inline-supplementary-material> (pdf) for a summary of additional pathogenic variants not discussed in this review. For more information, see <related-object source-id="gene" document-id="ml4" object-id="ml4.molgen.TA">Table A</related-object>.</p>
          <p>The variant c.1221_1223delCTT (<xref ref-type="table" rid="ml4.T.selected_mcoln1_pathogenic_variant">p.Phe408del</xref>), located in the fourth transmembrane domain, causes the mildest mucolipidosis IV phenotype known [<xref ref-type="bibr" rid="ml4.REF.altarescu.2002.306">Altarescu et al 2002</xref>]. In vitro the protein construct with this pathogenic variant still functions as a channel in liposome preparations and only displays a deficiency in regulation [<xref ref-type="bibr" rid="ml4.REF.raychowdhury.2004.617">Raychowdhury et al 2004</xref>]. Overexpressed Phe408del variant retains Fe2+ channel permeability as indicated by Patch-clamping of late-endosomal and lysosomal membrane [<xref ref-type="bibr" rid="ml4.REF.dong.2008.992">Dong et al 2008</xref>], possibly underlying the milder disease phenotype in this individual.</p>
          <table-wrap id="ml4.T.selected_mcoln1_pathogenic_variant" orientation="portrait" position="anchor">
            <label>Table 3. </label>
            <caption>
              <p>Selected <italic toggle="yes">MCOLN1</italic> Pathogenic Variants</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                  <th id="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                  <th id="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequence</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.406-2A&#x0003e;G<break/>(IVS3-2A&#x0003e;G)</td>
                  <td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/260763972">NM_020533.2</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/9844925">AF287270</ext-link>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">6.4-kb deletion<break/>(g.511_6943del)</td>
                  <td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Deletion of exons 1-5 and part of exon 6</td>
                  <td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/9844925">AF287270</ext-link>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.694A&#x0003e;C</td>
                  <td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Thr232Pro</td>
                  <td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_3" rowspan="6" valign="middle" align="left" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/260763972">NM_020533.2</ext-link>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1084G&#x0003e;T</td>
                  <td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Asp362Tyr</td>
                </tr>
                <tr>
                  <td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1221_1223delCTT</td>
                  <td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Phe408del</td>
                </tr>
                <tr>
                  <td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1406A&#x0003e;G&#x000a0;<sup>2</sup><break/>(g.9107A&#x0003e;G)</td>
                  <td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Phe454_Asn569del</td>
                </tr>
                <tr>
                  <td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_1" valign="bottom" align="left" scope="row" rowspan="1" colspan="1">c.1704A&#x0003e;T&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">See footnote 3</td>
                </tr>
                <tr>
                  <td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_1" valign="bottom" align="left" scope="row" rowspan="1" colspan="1">c.1615delG&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_ml4.T.selected_mcoln1_pathogenic_variant_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ala539ProfsTer41&#x000a0;<sup>4</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
              <fn id="ml4.TF.3.1">
                <label>1. </label>
                <p>Variant designation that does not conform to current naming conventions</p>
              </fn>
              <fn id="ml4.TF.3.2">
                <label>2. </label>
                <p>Base pair transition creates a new preferred splice acceptor site that results in a frameshift.</p>
              </fn>
              <fn id="ml4.TF.3.3">
                <label>3. </label>
                <p>Near the donor site of intron 13; creates an alternative donor splice site that results in a frameshift [<xref ref-type="bibr" rid="ml4.REF.dobrovolny.2007.663">Dobrovolny et al 2007</xref>]</p>
              </fn>
              <fn id="ml4.TF.3.4">
                <label>4. </label>
                <p>
                  <xref ref-type="bibr" rid="ml4.REF.goldin.2008.3134">Goldin et al [2008]</xref>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold> Mucolipin-1 is a 580-amino acid protein that is a member of the transient receptor potential (TRP) family. Proteins of this family are generally considered Ca<sup>2+</sup> channels. Mucolipin-1 has a high homology to mucolipin-2 and mucolipin-3. It also shows homologies to polycystin-2, the product of <italic toggle="yes">PKD2</italic>, one of two genes associated with <related-object link-type="booklink" source-id="gene" document-id="pkd-ad" document-type="chapter">autosomal dominant polycystic kidney disease</related-object>. Mucolipin-1 and polycystin-2 function as nonselective cation channels in heterologous expression systems [<xref ref-type="bibr" rid="ml4.REF.fares.2001.64">Fares &#x00026; Greenwald 2001</xref>, <xref ref-type="bibr" rid="ml4.REF.laplante.2002.183">LaPlante et al 2002</xref>, <xref ref-type="bibr" rid="ml4.REF.slaugenhaupt.2002.445">Slaugenhaupt 2002</xref>, <xref ref-type="bibr" rid="ml4.REF.raychowdhury.2004.617">Raychowdhury et al 2004</xref>, <xref ref-type="bibr" rid="ml4.REF.treusch.2004.4483">Treusch et al 2004</xref>].</p>
          <p><bold>Abnormal gene product.</bold> Most pathogenic variants are null alleles resulting in no gene product. When an abnormal gene product exists, it is a nonfunctional protein.</p>
        </sec>
      </sec>
      <sec id="ml4.References">
        <title>References</title>
        <sec id="ml4.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="ml4.Literature_Cited.reflist0">
            <ref id="ml4.REF.altarescu.2002.306">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Altarescu</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiggs</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Solomon</surname>
                    <given-names>BI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patronas</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frei</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gupta</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaneski</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quarrell</surname>
                    <given-names>OW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slaugenhaupt</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>The neurogenetics of mucolipidosis type IV.</article-title>
                <source>Neurology</source>
                <volume>59</volume>
                <fpage>306</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">12182165</pub-id>
              </element-citation>
            </ref>
            <ref id="ml4.REF.bach.2001.197">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bach</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Mucolipidosis type IV.</article-title>
                <source>Mol Genet Metab</source>
                <volume>73</volume>
                <fpage>197</fpage>
                <lpage>203</lpage>
                <pub-id pub-id-type="pmid">11461186</pub-id>
              </element-citation>
            </ref>
            <ref id="ml4.REF.bargal.2000.118">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bargal</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Avidan</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben-Asher</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olender</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeigler</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frumkin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raas-Rothschild</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glusman</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lancet</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bach</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Identification of the gene causing mucolipidosis type IV.</article-title>
                <source>Nat Genet</source>
                <volume>26</volume>
                <fpage>118</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">10973263</pub-id>
              </element-citation>
            </ref>
            <ref id="ml4.REF.bargal.2001.397">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bargal</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Avidan</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olender</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben Asher</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeigler</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raas-Rothschild</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frumkin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben-Yoseph</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedlender</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lancet</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bach</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Mucolipidosis type IV: novel MCOLN1 mutations in Jewish and non-Jewish patients and the frequency of the disease in the Ashkenazi Jewish population.</article-title>
                <source>Hum Mutat</source>
                <volume>17</volume>
                <fpage>397</fpage>
                <lpage>402</lpage>
                <pub-id pub-id-type="pmid">11317355</pub-id>
              </element-citation>
            </ref>
            <ref id="ml4.REF.bargal.2002.199">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bargal</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goebel</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Latta</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bach</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Mucolipidosis IV: novel mutation and diverse ultrastructural spectrum in the skin.</article-title>
                <source>Neuropediatrics</source>
                <volume>33</volume>
                <fpage>199</fpage>
                <lpage>202</lpage>
                <pub-id pub-id-type="pmid">12368990</pub-id>
              </element-citation>
            </ref>
            <ref id="ml4.REF.bassi.2000.1110">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bassi</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manzoni</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monti</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pizzo</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ballabio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borsani</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Cloning of the gene encoding a novel integral membrane protein, mucolipidin-and identification of the two major founder mutations causing mucolipidosis type IV.</article-title>
                <source>Am J Hum Genet</source>
                <volume>67</volume>
                <fpage>1110</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">11013137</pub-id>
              </element-citation>
            </ref>
            <ref id="ml4.REF.dobrovolny.2007.663">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dobrovolny</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liskova</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ledvinova</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poupetova</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asfaw</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filipec</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jirsova</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraus</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elleder</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Mucolipidosis IV: report of a case with ocular restricted phenotype caused by leaky splice mutation.</article-title>
                <source>Am J Ophthalmol</source>
                <volume>143</volume>
                <fpage>663</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">17239335</pub-id>
              </element-citation>
            </ref>
            <ref id="ml4.REF.dong.2008.992">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dong</surname>
                    <given-names>XP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheng</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mills</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delling</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kurz</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel.</article-title>
                <source>Nature.</source>
                <year>2008</year>
                <volume>455</volume>
                <fpage>992</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">18794901</pub-id>
              </element-citation>
            </ref>
            <ref id="ml4.REF.edelmann.2002.1023">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Edelmann</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dong</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desnick</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kornreich</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Carrier screening for mucolipidosis type IV in the American Ashkenazi Jewish population.</article-title>
                <source>Am J Hum Genet</source>
                <volume>70</volume>
                <fpage>1023</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11845410</pub-id>
              </element-citation>
            </ref>
            <ref id="ml4.REF.fares.2001.64">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fares</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenwald</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Regulation of endocytosis by CUP-5, the Caenorhabditis elegans mucolipin-1 homolog.</article-title>
                <source>Nat Genet</source>
                <volume>28</volume>
                <fpage>64</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11326278</pub-id>
              </element-citation>
            </ref>
            <ref id="ml4.REF.frei.1998.565">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Frei</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patronas</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crutchfield</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Altarescu</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Mucolipidosis type IV: characteristic MRI findings.</article-title>
                <source>Neurology</source>
                <volume>51</volume>
                <fpage>565</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9710036</pub-id>
              </element-citation>
            </ref>
            <ref id="ml4.REF.goldin.2008.3134">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goldin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caruso</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benko</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaneski</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stahl</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Isolated ocular disease is associated with decreased mucolipin-1 channel conductance.</article-title>
                <source>Invest Ophthalmol Vis Sci.</source>
                <year>2008</year>
                <volume>49</volume>
                <fpage>3134</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">18326692</pub-id>
              </element-citation>
            </ref>
            <ref id="ml4.REF.goldin.1999.8562">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goldin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cooney</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaneski</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brady</surname>
                    <given-names>RO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Mucolipidosis IV consists of one complementation group.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <volume>96</volume>
                <fpage>8562</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">10411915</pub-id>
              </element-citation>
            </ref>
            <ref id="ml4.REF.goldin.2004a.460">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goldin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stahl</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cooney</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaneski</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gupta</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brady</surname>
                    <given-names>RO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellis</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2004a</year>
                <article-title>Transfer of a mitochondrial DNA fragment to MCOLN1 causes an inherited case of mucolipidosis IV.</article-title>
                <source>Hum Mutat</source>
                <volume>24</volume>
                <fpage>460</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15523648</pub-id>
              </element-citation>
            </ref>
            <ref id="ml4.REF.goldin.b">
              <mixed-citation publication-type="book">Goldin M, Slaugenhaupt SA, Smith JA, Schiffmann R. Mucolipidosis type IV. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, eds. <italic toggle="yes">The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID)</italic>. Chap 138.1. New York, NY: McGraw-Hill. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://ommbid.mhmedical.com/">online</ext-link>. 2004b.</mixed-citation>
            </ref>
            <ref id="ml4.REF.laplante.2002.183">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>LaPlante</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falardeau</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanazirska</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slaugenhaupt</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vassilev</surname>
                    <given-names>PM</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Identification and characterization of the single channel function of human mucolipin-1 implicated in mucolipidosis type IV, a disorder affecting the lysosomal pathway.</article-title>
                <source>FEBS Lett</source>
                <volume>532</volume>
                <fpage>183</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12459486</pub-id>
              </element-citation>
            </ref>
            <ref id="ml4.REF.manzoni.2004.219">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Manzoni</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monti</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bresciani</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bozzato</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barlati</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bassi</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borsani</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Overexpression of wild-type and mutant mucolipin proteins in mammalian cells: effects on the late endocytic compartment organization.</article-title>
                <source>FEBS Lett</source>
                <volume>567</volume>
                <fpage>219</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">15178326</pub-id>
              </element-citation>
            </ref>
            <ref id="ml4.REF.pradhan.2002.45">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pradhan</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atchaneeyasakul</surname>
                    <given-names>LO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Appukuttan</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mixon</surname>
                    <given-names>RN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McFarland</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Billingslea</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stout</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weleber</surname>
                    <given-names>RG</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Electronegative electroretinogram in mucolipidosis IV.</article-title>
                <source>Arch Ophthalmol</source>
                <volume>120</volume>
                <fpage>45</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">11786056</pub-id>
              </element-citation>
            </ref>
            <ref id="ml4.REF.raychowdhury.2004.617">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Raychowdhury</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonz&#x000e1;lez-Perrett</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montalbetti</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timpanaro</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chasan</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldmann</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stahl</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cooney</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cantiello</surname>
                    <given-names>HF</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Molecular pathophysiology of mucolipidosis type IV: pH dysregulation of the mucolipin-1 cation channel.</article-title>
                <source>Hum Mol Genet</source>
                <volume>13</volume>
                <fpage>617</fpage>
                <lpage>27</lpage>
                <pub-id pub-id-type="pmid">14749347</pub-id>
              </element-citation>
            </ref>
            <ref id="ml4.REF.schaheen.2006.382">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schaheen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fares</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Basis of lethality in C. elegans lacking CUP-5, the mucolipidosis type IV orthologue.</article-title>
                <source>Dev Biol</source>
                <volume>293</volume>
                <fpage>382</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">16530747</pub-id>
              </element-citation>
            </ref>
            <ref id="ml4.REF.schiffmann.1998.1207">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dwyer</surname>
                    <given-names>NK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lubensky</surname>
                    <given-names>IA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsokos</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutliff</surname>
                    <given-names>VE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Latimer</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frei</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brady</surname>
                    <given-names>RO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barton</surname>
                    <given-names>NW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blanchette-Mackie</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldin</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Constitutive achlorhydria in mucolipidosis type IV.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>95</volume>
                <fpage>1207</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">9448310</pub-id>
              </element-citation>
            </ref>
            <ref id="ml4.REF.schiffmann.2014.147">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayfield</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swift</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nestrasil</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <article-title>Quantitative neuroimaging in mucolipidosis type IV.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2014</year>
                <volume>111</volume>
                <fpage>147</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">24332805</pub-id>
              </element-citation>
            </ref>
            <ref id="ml4.REF.siegel.1998.400">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Siegel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frei</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenfield</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Electroencephalographic findings in patients with mucolipidosis type IV.</article-title>
                <source>Electroencephalogr Clin Neurophysiol</source>
                <volume>106</volume>
                <fpage>400</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">9680151</pub-id>
              </element-citation>
            </ref>
            <ref id="ml4.REF.slaugenhaupt.2002.445">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Slaugenhaupt</surname>
                    <given-names>SA</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>The molecular basis of mucolipidosis type IV.</article-title>
                <source>Curr Mol Med</source>
                <volume>2</volume>
                <fpage>445</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">12125810</pub-id>
              </element-citation>
            </ref>
            <ref id="ml4.REF.smith.2002.588">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Noninvasive diagnosis and ophthalmic features of mucolipidosis type IV.</article-title>
                <source>Ophthalmology</source>
                <volume>109</volume>
                <fpage>588</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">11874766</pub-id>
              </element-citation>
            </ref>
            <ref id="ml4.REF.sun.2000.2471">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stahl</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falardeau</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kennedy</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Acierno</surname>
                    <given-names>JS</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Bove</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaneski</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bromley</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slaugenhaupt</surname>
                    <given-names>SA</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel.</article-title>
                <source>Hum Mol Genet</source>
                <volume>9</volume>
                <fpage>2471</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11030752</pub-id>
              </element-citation>
            </ref>
            <ref id="ml4.REF.treusch.2004.4483">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Treusch</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knuth</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slaugenhaupt</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grant</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fares</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Caenorhabditis elegans functional orthologue of human protein h-mucolipin-1 is required for lysosome biogenesis.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>101</volume>
                <fpage>4483</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15070744</pub-id>
              </element-citation>
            </ref>
            <ref id="ml4.REF.wang.2001.87">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>ZH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeng</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pastores</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raksadawan</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ong</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kolodny</surname>
                    <given-names>EH</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Rapid detection of the two common mutations in Ashkenazi Jewish patients with mucolipidosis type IV.</article-title>
                <source>Genet Test</source>
                <volume>5</volume>
                <fpage>87</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">11551108</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="ml4.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="ml4.Author_History">
          <title>Author History</title>
          <p>Ehud Goldin, PhD (2004-present)Yulia Grishchuk, PhD (2015-present)Raphael Schiffmann, MD, MHSc (2004-present)Susan A Slaugenhaupt, PhD; Harvard Medical School (2004-2015)Janine Smith, MD; National Institutes of Health (2004-2015)</p>
        </sec>
        <sec id="ml4.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>30 July 2015 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>20 July 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>6 June 2007 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>1 December 2005 (rs) Revision: sequence analysis no longer clinically available</p>
            </list-item>
            <list-item>
              <p>28 January 2005 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>16 August 2004 (rs) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
